Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.
3 reports, 3 independent
Updated Aug 17
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Collaboration between IONQ, AstraZeneca, and Amazon demonstrates quantum-accelerated chemistry workflow using AWS infrastructure.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Nvidia, IonQ, AstraZeneca, and AWS are partnering to demonstrate advanced computing workflows using a standard CPU.Sub-event
Collaboration uses IONQ and Amazon AWS to accelerate chemistry workflows for AstraZeneca.1 source
IONQ and AstraZeneca collaboration achieved speed-ups in drug development using quantum computing.1 source
Keep exploring
The entities involved
-
IONQ
quantum computing company based in College Park, MD, USA
-
AstraZeneca
British-Swedish pharmaceutical company
-
Amazon
American multinational technology company
Related events
Coverage
Newest first; wire copies grouped- Motley Fool3 Tech Stocks That Could Go Parabolic IonQ has the opportunity to be the big winner in quantum computing. SoundHound AI is looking to be a leader in voice and agentic AI. AppLovin has a huge opportun
- ZacksIonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead? IonQ IONQ is rapidly positioning itself as a preferred partner for both commercial enterprises and government institutions worldwide. Th
- Business WireIonQ Announces Second Quarter Financial Results Beats Top End Revenue Guidance by 15% Announced $1.075 Billion Proposed Acquisition of Oxford Ionics, Enhancing Scalable Quantum Computing Breakthrough